Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06654765

Growth and Development of Children With Inborn Errors of Metabolism in Assiut Governorate

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
201 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
1 Month – 5 Years
Healthy volunteers
Not accepted

Summary

Assessment of growth and development of children with inborn errors of metabolism in Assiut Governorate

Detailed description

Inborn errors of metabolism (IEM) are diseases resulting in deficient activity of an individual enzyme, structural protein in an intermediate metabolic pathway, present clinically in a wide variety of ways a ranging from non-specific chronic issues such as childhood delay in attaining development milestones, to acute decompensation. The prevalence of all of inborn errors of metabolism globally is 50.9/100000 live birth, In Egypt the prevalence among clinically suspected children is 7.8%. A study conducted in Minia Governorate (Egypt) on children less than 18 years included 67 children showed that 65.7% of children were under height. Also a study conducted in upper Egypt on 113 PKU patients showed that global developmental delay 54.9% was the most frequent presentations of PKU children. Parents of children with IEM face many challenges; as the financial burden and perceived restrictions in all aspects of life, discrimination by society in general, and the main challenge is dietary restrictions. Rationale: Despite being rare in Egypt, IEM are regarded as a national priority because of the substantial health burden they place on the growth and development of the affected children, which can range from delayed achievement of developmental milestones to acute decompensation and death. However, there is lack of longitudinal studies in Egypt that focus on how IEM affect physical development and growth, as well as the difficulties parents encounter while caring for their children and following up with them. To our knowledge, no local studies have been conducted in this field before.

Conditions

Timeline

Start date
2025-08-01
Primary completion
2026-10-01
Completion
2026-12-01
First posted
2024-10-23
Last updated
2024-10-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06654765. Inclusion in this directory is not an endorsement.